Cost and Cost-Effectiveness Analysis with Censored Data
Cost assessment and cost-effectiveness analysis serve as an essential part in the economic evaluation of medical interventions. In clinical trials and many observational studies, cost data as well as survival data are often incomplete due to patients’ loss to follow up or administrative termination of the study. There are numerous well-established statistical methodologies and software available for analyzing censored survival data. However, standard techniques for survival-type data are invalid in analyzing censored cost data, due to ...